INTRODUCTION
Gastrointestinal diseases can have many important extra-intestinal features, and the early identification and resolution may not only impact current symptoms but is also important for preventing long term complications. Ophthalmological features can be varied and may rarely present as an ophthalmological emergency, with early identification and treatment being paramount to good outcomes. A good knowledge of these features can be advantageous in not only helping disease diagnosis and ruling out differentials, but it may also play a role in monitoring disease progression or treatment toxicity. As
Gastroenterologists play a significant role in the follow-up of these patients, up-to-date knowledge of common ophthalmological signs, symptoms and management is vital to prevent long term complications that may be sight-threatening. This review will detail common and important ocular features of inflammatory bowel disease and other hepatobiliary disorders, including their epidemiology, features, treatment and complications. This is guided by competencies from the Gastroenterology curriculum as outlined in table 1. [1] Specialty Training Curriculum for Gastroenterology 2010 (Amendments 2013) ( 
SPECIALTY CERTIFICATE EXAM STYLE BEST-OF-FIVE QUESTIONS Question 1
A 45-year old man who with a past medical history of Crohn's disease calls the IBD-nurse led telephone helpline complaining of three-day history of a painful left eye.
He is seen in clinic that afternoon and also complains of light-sensitivity. His eye is generally red (fig 1) with some tearing evident.
What is the most appropriate initial treatment? 
Correct answer a) Topical Steroids
He has symptoms suggestive of acute anterior uveitis. The disease course runs independent of bowel inflammation and is managed initially with topical steroids.
Question 2
A 43-year old-man with a past medical history of Hepatitis C in a sustained virologic response (SVR) is under investigation for deranged liver function tests.
He is referred to ophthalmology for slit lamp investigation, which showed pigmented rings at the iris-scleral junction.
What gene is affected in this condition? 
OCULAR MANIFESTATIONS IN INFLAMMATORY BOWEL DISEASE Episcleritis
Episcleritis is one of three classic ocular complications of inflammatory bowel disease (IBD), others including scleritis and uveitis (table 2). It is reported to occur in 29% of IBD patients and is related to the severity of disease, with flares paralleling intestinal activity, thus may be used as an indicator of disease severity. [3] It is benign and self-limiting, and more commonly affects women.[4] [4] The episcleral layer is affected, which is a blood-rich layer between the conjunctiva and sclera ( fig. 2 ). [2] Characteristically, it involves injection of superficial episcleral vessels and overlying conjunctiva, which are mobile to palpation and blanch with topical phenylephrine.
There is sparing of the scleral vessels that give the sclera a white appearance between dilated red episcleral vessels ( fig. 3a ). [5] The pattern of inflammation may be nodular or diffuse, unilateral or bilateral. Symptoms include mild pain, tenderness on palpation, and/or tearing. Notably, there is no change in vision and the pupillary response remains intact. It is diagnosed clinically and should be suspected in those with an active flare of IBD who present with acute unilateral or bilateral redness, irritation or burning. An important differential includes conjunctivitis ( fig. 3b ), [6] which may be differentiated by a more unilateral presentation initially, with a watery or purulent discharge, itching and a lesser degree of ocular pain. It is the commonest cause of a red eye in the general population, however no known association with IBD has yet been proven. [7] Management includes treatment of the underlying IBD, resulting in a rapid resolution of the inflammation of the episcleral vessels. For short term symptomatic relief, use of a cool compresses or topical steroids may be effective. More severe symptoms may warrant the use of topical non-steroidal anti-inflammatory drugs (NSAIDs), although its use is limited due to its potential association with IBD flares. Infliximab has been shown to be effective in refractory episcleritis associated with IBD. [7] 
Scleritis
Scleritis is a less common extra-intestinal manifestation of IBD, occurring in roughly 18% of IBD patients, commonly affecting women and an older patient group than that seen in episcleritis. Conversely, only approximately 2% of scleritis cases are associated with IBD, with more common systemic disease associations including rheumatoid arthritis and granulomatosis with polyangiitis. [8] It may occur during inactive IBD phases and thus may not be a reliable disease-severity indicator. [3] The inflammation mostly affects the anterior sclera, it may be diffuse or focal, and is unilateral in up to 2/3 rds of cases. In scleritis, injection of the deeper scleral vessels (as well as episcleral and conjunctival involvement) results in hyperaemia ( fig. 3c ). The injected vessels are non-blanching with phenylephrine application and are immobile on palpation with a cotton-tip applicator, in contrast to episcleritis. Classically, the inflamed sclera have been described as appearing blue or violet under natural light. Typically, a deeper more severe ocular and periorbital pain is reported compared to episcleritis, with tenderness on palpation. Rarely, involvement of the posterior sclera results in visual loss, which may be complicated by retinal detachment or optic neuritis (swelling of the nerve head) which may result in a permanent visual impairment. Thus, prompt referral to an ophthalmologist is important, for rapid diagnosis and aggressive management. Scleritis can commonly recur, although effective control of the underlying IBD may reduce this risk. [7] This is significant as scleromalacia perforans (thinning of the sclera) may occur as a consequence of recurrences. [4] Due to the potentially serious complications, management is aggressive and includes NSAIDs, systemic steroids or immunosuppressant drugs (e.g. methotrexate) in order of increasing severity. [7] Uveitis Uveitis is thought to present less commonly than episcleritis, with a prevalence of roughly 1.5-3% in those with IBD, occurring more commonly in females. It does not parallel the underlying activity of the IBD, and often presents insidiously, with a chronic course of up to 6 months, with a risk of recurrence. [9] There is an association between dermatological (namely erythema nodosum) and joint symptoms in IBD where uveitis presents. Furthermore, a link between acute iritis and HLA-B27 expression, sacroiliitis and Crohn's disease has been described. [2] Uveitis can be separated by anatomical structures involved ( fig. 2 4 ), where the miotic pupil results in an attachment between the iris and cornea or lens, which can result in long term complications including secondary glaucoma and cataract formation. [7] Prompt management is required and includes a cycloplegic agent to avoid synechiae formation and provide pain relief, alongside topical steroids. In more severe cases, systemic steroids or immunomodulatory drugs may be used. [7] Cataracts Cataract formation occurs as a treatment-related ophthalmological manifestation of IBD, with prolonged steroid use resulting in posterior subcapsular cataract formation. There is thought to be a dose dependent relationship, although individual predisposition and genetic factors complicates this relationship. For example, children are more vulnerable and experience a more rapid progression of cataract formation. A 'safe dose' is controversial, although it has previously been quoted as less than 10mg daily of prednisolone, for less than a year [10] . It is also thought that other prior ocular manifestations of IBD (e.g. uveitis) can lead to secondary cataract formation. [11] This may be asymptomatic, or may cause insidious and progressive reduced acuity, and patients may typically report glare at night around light sources. Treatment include surgical lens removal and replacement. [7] Cataract formation can also occur as a complication of congenital galactosaemia (CG), due to accumulation of by-products (galactitol) from alternate galactose metabolism pathways.
This can occur in the neonatal period, with a prevalence of roughly 6-25%. It presents bilaterally with a characteristic appearance on slit lamp examination, notably with no impact on visual acuity. Management includes maintaining a galactose-restricted diet (including using milk substitutes), which will often result in cataract resolution. Dietary adherence is also important in preventing severe cataracts in later life, although reduced visual acuity requiring surgery is very rare. [12] 
Optic Disc Drusen
Ocular disc drusen are one of the many ophthalmological findings that may be seen in Alagille syndrome, although they may also be seen in up to 15% of the normal population.
Along with evidence of posterior embryotoxon (white line appearing anterior to limbus during slit lamp examination due to displacement of Schwalbe's line), these ocular signs can be used to form part of the clinical diagnostic criteria of the syndrome. [19] Other ocular findings are less common, and include retinal pigment granularity, 
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